You have 6 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

high grade serous carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer, Relapsed Ovarian Cancer, Fallopian Tube Cancer Trial (Carboplatin)

Not yet recruiting
  • Ovarian Cancer
  • +6 more
  • (no location specified)
Oct 27, 2022

Investigate Adaptation and Evolution of Ovarian High-grade

Recruiting
  • Ovarian Cancer
  • +6 more
    • Bristol, United Kingdom
    • +10 more
    Sep 8, 2022

    High Grade Serous Adenocarcinoma of Ovary, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial (Sovilnesib)

    Not yet recruiting
    • High Grade Serous Adenocarcinoma of Ovary
    • +3 more
    • (no location specified)
    Oct 13, 2023

    Chromosomal Instability in Ovarian Cancer

    Recruiting
    • Epithelial Ovarian Cancer
    • +7 more
    • Testing for chromosomal instability (CIN)
    • Beijing, Beijing, China
      Lei Li
    Mar 26, 2022

    High Grade Serous Ovarian Cancer (HGSOC) Trial (FAPI PET CT)

    Not yet recruiting
    • High Grade Serous Ovarian Cancer (HGSOC)
    • FAPI PET CT
    • (no location specified)
    Jul 20, 2023

    High Grade Serous Carcinoma, Triple Negative Breast Cancer, Ovarian Cancer Trial (Olaparib tablet, Navitoclax)

    Recruiting
    • High Grade Serous Carcinoma
    • +2 more
    • Toronto, Ontario, Canada
    • +2 more
    Nov 28, 2022

    Cytoreductive Surgery, Grade 3 Endometrial Endometrioid Adenocarcinoma, High Grade Serous Carcinoma Trial in Boston (PET/MRI

    Not yet recruiting
    • Cytoreductive Surgery
    • +4 more
    • PET/MRI with radiotracer ([18F]- fluorodeoxyglucose) and a gadolinium-based contrast agent
    • Boston, Massachusetts
      Massachusetts General Hospital
    May 21, 2022

    BRCA1 Mutation, BRCA2 Mutation, Ovarian Cancer Trial in Providence (Talazoparib Oral Capsule)

    Active, not recruiting
    • BRCA1 Mutation
    • +4 more
    • Talazoparib Oral Capsule
    • Providence, Rhode Island
    • +1 more
    Nov 30, 2022

    Gynecologic Cancer, Ovarian Cancer, High Grade Serous Carcinoma Trial in Ljubljana (Carboplatin)

    Recruiting
    • Gynecologic Cancer
    • +3 more
    • Ljubljana, Slovenia
    • +1 more
    Aug 6, 2022

    New Prognostic Index for Neoadjuvant Chemotherapy Outcome in

    Enrolling by invitation
    • Ovarian Cancer
    • +2 more
    • CRS scoring
    • Routine blood laboratory testing before treatment
    • Guangzhou, Guangdong, China
      The Sun Yat-sen Memorial Hospital of Sun Yat-sen University
    Nov 2, 2023

    Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in

    Recruiting
    • Fallopian Tube Carcinosarcoma
    • +28 more
    • Pegylated Liposomal Doxorubicin Hydrochloride
    • Peposertib
    • Aurora, Colorado
    • +7 more
    Sep 2, 2022

    Tumor, Ovarian, Fallopian Tube Cancer, Primary Peritoneal Cavity Cancer Trial (AVB-001 (Dose Escalation Phase), AVB-001 (Dose

    Not yet recruiting
    • Neoplasm, Ovarian
    • +7 more
    • AVB-001 (Dose Escalation Phase)
    • AVB-001 (Dose Expansion Phase)
    • (no location specified)
    Sep 15, 2022

    Fallopian Tube Carcinosarcoma, Primary Peritoneal Carcinosarcoma, Recurrent Fallopian Tube Carcinoma Trial in Rochester (Biopsy,

    Not yet recruiting
    • Fallopian Tube Carcinosarcoma
    • +14 more
    • Biopsy
    • +6 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jun 28, 2023

    Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary, High Grade Endometrioid Ovarian Cancer Trial in Guangzhou (Fluzoparib

    Not yet recruiting
    • Ovarian Cancer
    • +4 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Cetntre
    Sep 25, 2023

    Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

    Recruiting
    • Fallopian Tube Endometrioid Adenocarcinoma
    • +17 more
    • Biopsy
    • +3 more
    • Augusta, Georgia
    • +4 more
    Jan 25, 2023

    Ovarian Carcinoma Trial (PEP-DC1, OC-DC, PEP-DC2)

    Not yet recruiting
    • Ovarian Carcinoma
    • PEP-DC1
    • +3 more
    • (no location specified)
    Jan 26, 2023

    High Grade Serous Ovarian Cancer Trial in Montpellier (Blood sample and tissue sample)

    Not yet recruiting
    • High Grade Serous Ovarian Cancer
    • Blood sample and tissue sample
    • Montpellier, France
      NOUGARET Stephanie
    Oct 10, 2023

    Ovarian Cancer, High Grade Ovarian Serous Trial in New York (PET/MRI, Contrast enhanced CT)

    Active, not recruiting
    • Ovarian Cancer
    • High Grade Ovarian Serous
    • PET/MRI
    • Contrast enhanced CT
    • New York, New York
      Memorial Sloan Kettering Cancer Center (All Protocol Activities)
    Mar 2, 2022

    Platinum-resistant Ovarian Cancer Trial in China (IN10018 in combination with PLD)

    Recruiting
    • Platinum-resistant Ovarian Cancer
    • IN10018 in combination with PLD
    • Anyang, China
    • +6 more
    Sep 20, 2022

    High Grade Serous Carcinoma Trial in Baltimore, Boston, Philadelphia (Olaparib Pill, AZD6738)

    Recruiting
    • High Grade Serous Carcinoma
    • Baltimore, Maryland
    • +2 more
    Mar 4, 2022

    Ovarian Cancer, Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Toronto (Niraparib)

    Not yet recruiting
    • Ovarian Cancer
    • +3 more
    • Toronto, Ontario, Canada
      Sunnybrook Research Institute
    Jul 18, 2023

    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Philadelphia (MOv19-BBz CAR T cells, Alpha Folate

    Recruiting
    • Ovarian Cancer
    • +2 more
    • MOv19-BBz CAR T cells
    • Alpha Folate Receptor expression test
    • Philadelphia, Pennsylvania
      University of Pennsylvania Health System
    Sep 12, 2022

    Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer Trial (VLS-1488)

    Not yet recruiting
    • Advanced Solid Tumor
    • +15 more
    • (no location specified)
    Jun 2, 2023

    Ovarian Cancer Trial in Kelowna, Vancouver, Kingston (Durvalumab, BA3011, BA3021)

    Recruiting
    • Ovarian Cancer
    • Kelowna, British Columbia, Canada
    • +4 more
    Nov 14, 2022

    miRNAs in High Grade Serous Ovarian Cancer

    Recruiting
    • High Grade Serous Ovarian Cancer
      • Bologna, Bo, Italy
        IRCCS- Azienda Ospedaliera-Universitaria di Bologna
      Dec 3, 2021